CDT Equity CDT
NASDAQ CDT
$0.40 -0.04 (-9.09%)
At close: Nov 13, 2026 · 4:00 PM EST

CDT Equity (CDT) EBITDA (2024 - 2026)

Updated

CDT Equity's EBITDA was -$2.69 million in Q2 2026, compared with -$4.58 million a year earlier.

Analysis

CDT Equity (CDT) EBITDA (2024 - 2026) Analysis & Trends

On a trailing twelve-month basis, CDT Equity's EBITDA was -$33.59 million through Jun 30, 2026; for FY2025, it came in at -$35.34 million.

  • In earlier years, EBITDA was -$13.74 million in FY2024.
  • Per Business Quant data, CDT's EBITDA in the three quarters before Q2 2026 was -$3.38 million (Q1 2026), -$20.88 million (Q4 2025) and -$6.64 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA (Qtr)
1 Eli Lilly 1,359.75 Bn 1,333.37 Bn 20.46 Bn 8.95 Bn
2 Johnson & Johnson 688.76 Bn 608.62 Bn 17.30 Bn 8.30 Bn
3 AbbVie 521.69 Bn 489.75 Bn 13.12 Bn 8.16 Bn
4 Merck 364.31 Bn 327.31 Bn 13.19 Bn 7.34 Bn
5 Novartis Ag 306.35 Bn 279.93 Bn - -
6 Astrazeneca 285.96 Bn 259.56 Bn 13.26 Bn 5.99 Bn
7 Amgen 251.88 Bn 203.53 Bn 7.58 Bn 4.83 Bn
8 Gilead Sciences 208.59 Bn 183.61 Bn 6.73 Bn 4.20 Bn
9 Pfizer 164.73 Bn 112.38 Bn 12.56 Bn 7.05 Bn
10 CDT Equity 426.40 -6.19 Mn - -2.22 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -2.22 Mn
Mar 31, 2026 -2.84 Mn
Dec 31, 2025 -20.37 Mn
Sep 30, 2025 -5.76 Mn
Jun 30, 2025 -3.75 Mn
Mar 31, 2025 -3.05 Mn
Dec 31, 2024 -2.35 Mn
API Access

CDT Equity EBITDA API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebitda&ticker=CDT&period=max&api_key=YOUR_API_KEY